[1] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640. [2] 满孝勇,李学平,冒长峙,等.系统性红斑狼疮疾病活动指数与治疗的关系探讨.中华皮肤科杂志,2002,35:17-19. [3] No authors listed. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.Arthritis Rheum, 1999, 42: 1785-1796. [4] Villalta D, Romelli PB, Savina C, et al. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus, 2003, 12: 31-36. [5] Schiffer LE, Hussain N, Wang X, et al. Lowering anti-dsDNA antibodies--what's new? Lupus, 2002,11: 885-894. [6] 谢红付,李吉,陈翔,等.系统性红斑狼疮疾病活动性与ANA及dsDNA抗体水平相关性探讨.中华皮肤科杂志,2003,36:404. [7] Yee CS, Hussein H, Skan J, et al. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford), 2003, 42: 276-279. |